1. Home
  2. GHRS vs IE Comparison

GHRS vs IE Comparison

Compare GHRS & IE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GHRS
  • IE
  • Stock Information
  • Founded
  • GHRS 2018
  • IE 2020
  • Country
  • GHRS Ireland
  • IE United States
  • Employees
  • GHRS N/A
  • IE N/A
  • Industry
  • GHRS Biotechnology: Pharmaceutical Preparations
  • IE Metal Mining
  • Sector
  • GHRS Health Care
  • IE Basic Materials
  • Exchange
  • GHRS Nasdaq
  • IE Nasdaq
  • Market Cap
  • GHRS 960.2M
  • IE 1.0B
  • IPO Year
  • GHRS 2021
  • IE 2022
  • Fundamental
  • Price
  • GHRS $14.38
  • IE $9.56
  • Analyst Decision
  • GHRS Strong Buy
  • IE Strong Buy
  • Analyst Count
  • GHRS 8
  • IE 3
  • Target Price
  • GHRS $30.63
  • IE $12.67
  • AVG Volume (30 Days)
  • GHRS 353.0K
  • IE 1.7M
  • Earning Date
  • GHRS 09-02-2025
  • IE 08-11-2025
  • Dividend Yield
  • GHRS N/A
  • IE N/A
  • EPS Growth
  • GHRS N/A
  • IE N/A
  • EPS
  • GHRS N/A
  • IE N/A
  • Revenue
  • GHRS N/A
  • IE $3,276,000.00
  • Revenue This Year
  • GHRS N/A
  • IE $64.50
  • Revenue Next Year
  • GHRS N/A
  • IE $0.73
  • P/E Ratio
  • GHRS N/A
  • IE N/A
  • Revenue Growth
  • GHRS N/A
  • IE N/A
  • 52 Week Low
  • GHRS $6.00
  • IE $4.50
  • 52 Week High
  • GHRS $20.50
  • IE $13.25
  • Technical
  • Relative Strength Index (RSI)
  • GHRS 46.75
  • IE 39.92
  • Support Level
  • GHRS $12.81
  • IE $11.00
  • Resistance Level
  • GHRS $15.28
  • IE $13.25
  • Average True Range (ATR)
  • GHRS 1.49
  • IE 0.82
  • MACD
  • GHRS -0.41
  • IE -0.30
  • Stochastic Oscillator
  • GHRS 20.60
  • IE 3.47

About GHRS GH Research PLC

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.

About IE Ivanhoe Electric Inc.

Ivanhoe Electric Inc is a United States-based d minerals exploration company with a focus on developing mines from mineral deposits principally located in the United States. The company has four business segments; Santa Cruz Project; critical metals; data processing services; and energy storage. It derives a majority of its revenue from Canada. The Santa Cruz Project and critical metals segments are focused on mineral project exploration and development. The data processing segment provides data analytics, geophysical modeling, and artificial intelligence services for the mineral, oil & gas, and water exploration industries. The energy storage segment develops, manufactures, and installs vanadium flow batteries for grid-scale energy storage.

Share on Social Networks: